737 filings
Page 23 of 37
POS AM
ee3gkmjclr90u
10 Mar 11
Prospectus update (post-effective amendment)
12:00am
8-K
rmx5u2a2yt xu
15 Feb 11
Adventrx Pharmaceuticals Provides Update on ANX-514
12:00am
8-K
aj9et7of2awmc y90h3q
14 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
32vg1p
19 Jan 11
Adventrx Pharmaceuticals Receives Pdufa Date for Exelbineâ„¢ Nda
12:00am
8-K
qu1cpmeq
7 Jan 11
Adventrx Pharmaceuticals Announces Capital Raise of $22.5 Million
12:00am
8-K
wikduw4 3o6cm1q1bn
7 Jan 11
Other Events
12:00am
424B5
cqlcwaj8se 0em3626
7 Jan 11
Prospectus supplement for primary offering
12:00am
424B5
8yx9rp0tarr
7 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
e8sli1g5v qyp8x
6 Jan 11
Other Events
12:00am
424B3
hisvec vipvcns0i
8 Nov 10
Prospectus supplement
12:00am
8-K
ks7gx nir4dvzv68tr
8 Nov 10
Adventrx Reports Third Quarter Financial Results
12:00am
8-K
rv2ix te5r8v4xnr
3 Nov 10
Other Events
12:00am
8-K
vz6gww5s
6 Oct 10
Other Events
12:00am
8-K
iqcgf5qm6nltp0b0h
14 Sep 10
Adventrx Announces 12-MONTH Stability Data Results for ANX-530
12:00am
424B3
v1ho9h
10 Aug 10
Prospectus supplement
12:00am
8-K
4rucv2we
6 Aug 10
Adventrx Reports Second Quarter Financial Results
12:00am
8-K
ad27cwox1 0qbipv
2 Jul 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5euvv8b4
30 Jun 10
Adventrx Announces 9-MONTH Stability Data Results for ANX-530
12:00am